Luminal B breast tumors are not HER2 positive.

Breast cancer research : BCR ·Vol. 10 ·No. 5 ·2008-00-00 ·Pages 404; author reply 405

Bhargava R, Dabbs DJ

Abstract

暂无摘要

MeSH Terms

Biomarkers, Tumor/analysis,genetics Breast Neoplasms/chemistry,classification,genetics Carcinoma, Ductal, Breast/chemistry,classification,genetics Carcinoma, Intraductal, Noninfiltrating/chemistry,classification,genetics Estrogens Female Gene Amplification Genes, erbB-2 Humans Immunohistochemistry In Situ Hybridization, Fluorescence Neoplasm Proteins/analysis,genetics Neoplasms, Hormone-Dependent/chemistry,genetics Receptor, ErbB-2/analysis Receptors, Estrogen/analysis,genetics

Chemicals

Biomarkers, Tumor Estrogens Neoplasm Proteins Receptors, Estrogen Receptor, ErbB-2

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Bhargava Rohit

Dabbs David J

References (11)

11 references, click to expand

HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring.
Am J Clin Pathol. 2004 May;121(5):631-6 PMID: 15151202
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 PMID: 11553815
Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison.
Breast Cancer Res Treat. 2001 Jun;67(3):263-71 PMID: 11561772
Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma.
Am J Clin Pathol. 2003 Jul;120(1):86-92 PMID: 12866377
Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay.
Am J Pathol. 2004 Jan;164(1):35-42 PMID: 14695316
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Breast Cancer Res. 2008;10(4):R67 PMID: 18681955
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.
Arch Pathol Lab Med. 1985 Aug;109(8):716-21 PMID: 3893381
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
J Clin Oncol. 1999 May;17(5):1474-81 PMID: 10334533
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
JAMA. 2006 Jun 7;295(21):2492-502 PMID: 16757721
Molecular classification of breast tumors: toward improved diagnostics and treatments.
Methods Mol Biol. 2007;360:91-114 PMID: 17172726
Histopathologic variables predict Oncotype DX recurrence score.
Mod Pathol. 2008 Oct;21(10):1255-61 PMID: 18360352

Article Info

Journal

Breast cancer research : BCR

Abbr.

Breast Cancer Res

ISSN

1465-542X

DOI

10.1186/bcr2134

Published

2008-00-00

Epub

2008-00-26

Pages

404; author reply 405

Language

English

Region

England

NLM ID

100927353

PMCID

PMC2614503

Subset

Corrections

CommentOn

PMID: 18681955

External Links

PubMed source DOI: 10.1186/bcr2134 PMC Full Text View journal details

Analysis Services

Luminal B breast tumors are not HER2 positive.

Contact

WeChat Official Account